KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Net Margin (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Net Margin for 16 consecutive years, with 40.11% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 3918.0% to 40.11% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 9.1% through Dec 2025, up 918.0% year-over-year, with the annual reading at 7.83% for FY2025, 2293.0% up from the prior year.
  • Net Margin for Q4 2025 was 40.11% at Biolife Solutions, up from 62.3% in the prior quarter.
  • The five-year high for Net Margin was 260.33% in Q4 2023, with the low at 179.8% in Q2 2022.
  • Average Net Margin over 5 years is 4.36%, with a median of 17.35% recorded in 2024.
  • The sharpest move saw Net Margin skyrocketed 19036bps in 2021, then crashed -20504bps in 2022.
  • Over 5 years, Net Margin stood at 42.21% in 2021, then soared by 382bps to 119.21% in 2022, then skyrocketed by 118bps to 260.33% in 2023, then tumbled by -70bps to 79.3% in 2024, then tumbled by -49bps to 40.11% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 40.11%, 62.3%, and 1.87% for Q4 2025, Q2 2025, and Q1 2025 respectively.